Infectious Diseases 公开
[search 0]
更多

Download the App!

show episodes
 
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
 
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
 
A public health podcast produced by the National Collaborating Centre for Infectious Diseases (NCCID), "Infectious Questions" connects those with infectious disease questions to those with the answers. Un balado sur la santé publique réalisé par le Centre de collaboration nationale des maladies infectieuses (CCNMI) et appelé « Infections en question » fait le lien entre les balados concernant les questions sur les maladies infectieuses et ceux qui offrent des réponses à ces questions.
 
The premier Infectious Diseases remote learning resource on the web! Enjoy more than 200 hours of video presentations for medical students, residents, and other health professionals. Complete podcast series is at www.idpodcasts.net. Sponsored by the Division of Infectious Diseases and International Medicine, University of South Florida College of Medicine, Tampa, Florida, Douglas Holt, MD, Division Director. John T. Sinnott, MD, Past Director, Chairman, Department of Internal Medicine Also S ...
 
Loading …
show series
 
Go online to PeerView.com/ZWH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Despite a widening array of effective HIV prevention tools and a massive scale-up of HIV treatment in recent years, there has been unequal progress with increasing access to treatment and reducing the number of new HI…
 
This podcast is a rerun of a December 2020 conversation with Dr. Kerry Sondgeroth, a veterinary bacteriologist at the Wyoming State Veterinary Laboratory and an associate professor at the University of Wyoming, and Sarah Gregory discussing a high-mortality outbreak of Mycoplasma bovis in free-ranging pronghorn in Wyoming.…
 
This is a repost of the May 2021 conversation with Dr. Ron Louie, a clinical professor in Pediatrics Hematology-Oncology at the University of Washington in Seattle, and Sarah Gregory, discussing his poem, "Isolation Cocoon, May 2020-After Zhuangzi's Butterfly Dream," which was inspired by the early events of the COVID pandemic.…
 
How reliable are at-home COVID-19 tests? Are there shortcomings to “testing out” of vaccine mandates? IDSA members Dial Hewlett, MD, FIDSA of the Westchester County Health Department and Nira Pollock, MD, FIDSA of Boston Children’s Hospital join us to discuss the latest on COVID-19 testing. *This episode was recorded on December 6, 2021.…
 
Go online to PeerView.com/ZWH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Despite a widening array of effective HIV prevention tools and a massive scale-up of HIV treatment in recent years, there has been unequal progress with increasing access to treatment and reducing the number of new HI…
 
In this episode recorded on December 13th, IDSA President-Elect Carlos del Rio, MD, FIDSA and IDSA Public Health Committee Chair Julie Vaishampayan, MD, FIDSA share what the medical community knows thus far about the Omicron variant, including its impact on current COVID-19 treatments and why testing plays a key role.…
 
Misinformation about COVID-19, including vaccines, treatments and the government’s role, has been fueling vaccine hesitancy. In this episode, IDSA President Dr. Daniel McQuillen, FIDSA, IDSA President-Elect Dr. Carlos del Rio, FIDSA and John Bridgeland, co-founder and CEO of the COVID Collaborative, discuss what is being done to combat misinformati…
 
In episode 38 of the OFID podcast, OFID Editor in Chief Paul Sax, MD, interviews Chris Stolarski, associate director of university communication at Marquette University, about his frightening experience with COVID-19 infection and hospitalization, and sharing his story to encourage others to get vaccinated.…
 
Go online to PeerView.com/VQJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. No single prevention method or approach can stop the HIV epidemic on its own. Several interventions have proved highly effective in reducing the risk of, and protecting against, HIV infection, including male and femal…
 
Go online to PeerView.com/VQJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. No single prevention method or approach can stop the HIV epidemic on its own. Several interventions have proved highly effective in reducing the risk of, and protecting against, HIV infection, including male and femal…
 
COVID-19 Treatment Guideline co-authors Rajesh Gandhi, MD, FIDSA of Harvard University and Adarsh Bhimraj, MD, FIDSA of the Cleveland Clinic give an update on COVID-19 therapeutics and discuss two recently published papers in Clinical Infectious Diseases. Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatmen…
 
Go online to PeerView.com/HNA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in infectious diseases discuss employing PrEP and HIV prevention strategies across all age groups. Upon completion of this activity, participants should be better able to: Describe the biolog…
 
Go online to PeerView.com/HNA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in infectious diseases discuss employing PrEP and HIV prevention strategies across all age groups. Upon completion of this activity, participants should be better able to: Describe the biolog…
 
Moderator Neil Skolnik, MD and IDSA COVID-19 Guidelines co-author John Lynch, MD, FIDSA discuss the new IDSA guidance on infection prevention for healthcare personnel caring for patients with suspected or known COVID-19. The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. …
 
Vaccination against the human papilloma virus, or HPV, all but eliminates cervical cancer in those who receive the vaccine early and complete the vaccine series, a study from the UK finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: The overall story is a really good one. They […]…
 
The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very much has been developed, and Brian Garibaldi, a critical care medicine expert at Johns Hopkins, […]…
 
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about the new monoclonal antibody, sotrovimab, this monoclonal antibody was …
 
Monoclonal antibodies remain a treatment option for those in early stages of Covid infection, even in the face of new oral medications that likely will be available soon. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says the data are persuasive. Garibaldi: High risk individuals who are household contacts of people who have […]…
 
Both Pfizer and Merck have recently revealed promising data on oral medicines for early Covid-19 infection, with both companies on the threshold of widespread use of the drugs. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says he hopes people don’t see these new medicines as a reason to forgo vaccination. Garibaldi: I […]…
 
Pfizer has asked the FDA to approve its new oral medication for Covid-19, called Paxlovid, for people in the early stages of infection. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, reviews the data. Garibaldi: From symptom onset to receipt of drug within about three days they had about 750 or so patients […]…
 
In honor of Native American Heritage Month, COVID-19 Real-Time Learning Network Associate Editor Mati Hlatshwayo Davis, MD, MPH, leads a panel discussion with Luke John Day, MD of UCSF, Sophie Neuner, MD, MPH of Johns Hopkins Center for American Indian Health, and Jessica Snowden, MD, FIDSA of UAMS. The group discusses the importance of visibility …
 
IDSA President Daniel McQuillen, MD, FIDSA is joined by Congresswoman Lori Trahan (D-MA) and IDSA Advocacy Liaison Kinna Thakarar, DO to discuss the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act, new bipartisan legislation that would provide loan repayment for medical professionals who work in bio-preparedness or provide infectio…
 
Dr. Paul Planet, an assistant professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania and at Children's Hospital Philadelphia, as well as a senior researcher at the Sackler Institute for Comparative Genomics at the American Museum of Natural History in New York, and Sarah Gregory discuss multidrug-resistant MRSA…
 
Loading …

快速参考指南

Google login Twitter login Classic login